After analyzing the biological effects of Lnc-CLSTN2-1:1 using in vitro assays, we present in vitro evidence supporting the oncogenic impact of Lnc-CLSTN2-1:1 in osteosarcoma. This evidence concerns the gene CLSTN2 and osteosarcoma.